S. 4091 · 117th Congress
Overdose Review Team Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 117th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
WhitehouseSponsor2 cosponsors · 1 D, 1 R
1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
This bill provides funding to the Department of Health and Human Services for grants that support drug overdose fatality review teams in states, Indian tribes, territories, and localities.
What it does: CRS summary · Introduced in Senate · Apr 27, 2022
Overdose Review Team Act
This bill provides funding to the Department of Health and Human Services for grants that support drug overdose fatality review teams in states, Indian tribes, territories, and localities. These multidisciplinary teams track fatal and nonfatal drug overdoses that occur in the jurisdiction to identify relevant trends and patterns and recommend policies and practices for preventing and reducing drug overdoses.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Overdose Review Team Act
Latest action (Apr 27, 2022): Read twice and referred to the Committee on Finance.
Policy area: Health · Origin: Senate · Introduced: Apr 27, 2022
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.